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Abstract
Introduction
Early  identification  of  cardiovascular  disease  (CVD) 
risk is important to reach people in need of treatment. 
At-risk  patients  benefit  from  behavioral  counseling  in 
addition to medical therapy. The objective of this study 
was  to  determine  whether  enhanced  counseling,  using 
patient  navigators  trained  to  counsel  patients  on  CVD 
risk-reducttion strategies and facilitate patient access to 
community-based lifestyle-change services, reduced CVD 
risk among at-risk patients in a low-income population.
Methods
We  compared  clinical  characteristics  at  baseline  and 
12-month  follow-up  among  340  intervention  and  340 
comparison  patients  from  community  health  centers  in 
Denver, Colorado, between March 2007 and June 2009; 
all patients had a Framingham risk score (FRS) greater 
or equal to 10% at baseline. The intervention consisted of 
patient-centered counseling by bilingual patient naviga-
tors. At baseline and at 6-month and 12-month follow-up, 
we assessed health behaviors of intervention participants. 
We used an intent-to-treat approach for all analyses and 
measured significant differences by χ2 and t tests.
Results
We  found  significant  differences  in  several  clinical 
outcomes.  At  follow-up,  the  mean  FRS  was  lower  for 
the  intervention  group  (mean  FRS,  15%)  than  for  the 
comparison group (mean FRS, 16%); total cholesterol was 
lower for the intervention group (mean total cholesterol, 
183  mg/dL)  than  for  the  comparison  group  (mean  total 
cholesterol, 197 mg/dL). Intervention participants reported 
significant improvements in some health behaviors at 12-
month  follow-up,  especially  nutrition-related  behaviors. 
Behaviors related to tobacco use and cessation attempts 
did not improve.
Conclusion
Patient navigators may provide some benefit in reducing 
risk of CVD in a similar population.
Introduction
The  Interheart  study  demonstrated  that  90%  of  the 
population-attributable risk of a first myocardial infarction 
is  due  to  modifiable  risk  factors  (1).  Many  people  in 
the  general  population  have  1  or  more  risk  factors  for 
cardiovascular disease (CVD), and more than 90% of CVD 
events occur in people with at least 1 risk factor (1,2).
Early  identification  of  CVD  risk  is  important  for  treat-
ing  at-risk  people.  The  National  Cholesterol  Education 
Program  guidelines  recommend  using  the  Framingham 
risk score (FRS) to identify people with an increased 10-
year  risk  for  coronary  heart  disease  (CHD)  events  (3). 
The evidence for using the FRS consists of large longitu-
dinal studies in which various models assessing multiple 
variables estimated the risk of CHD events (4). CHD is a 
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subset of CVD that excludes stroke, peripheral vascular 
disease, and heart failure.
The appropriate use of a risk score during a provider visit 
may  involve  recommendations  for  preventive  lifestyle 
change in addition to medical therapy (3). However, pre-
ventive services are often a low priority in a busy clini-
cal  practice  because  of  competing  demands,  inadequate 
insurance reimbursement, patient reticence to discuss or 
follow recommendations, and lack of provider expertise in 
counseling techniques or knowledge of community-based 
services (3-7).
Patient navigators have been effective for chronic disease 
prevention  and  management  activities  such  as  cancer 
screening  and  treatment,  assessment  of  primary  care 
services,  and  cardiovascular  health  promotion  (8-17). 
The  patient-navigator  model  has  been  suggested  as  an 
approach for facilitating CVD risk-reduction activities in 
conjunction with other clinical services (18).
The  objective  of  this  study  was  to  determine  whether 
enhanced  counseling,  using  patient  navigators  trained 
to counsel patients on CVD risk-reduction strategies and 
facilitate  patient  access  to  community-based  lifestyle-
change services, reduced CVD risk among at-risk patients 
in a low-income population.
Methods
Study design
We used a quasi-experimental pre–post (baseline and 12-
month  follow-up)  design  to  compare  changes  in  clinical 
outcomes among intervention participants with changes 
among a comparison group drawn from the same patient 
population. We used a nonexperimental pre–post (base-
line and 12-month follow-up) design to assess behavioral 
changes  among  the  intervention  participants  only.  We 
used an intent-to-treat approach for all analyses.
We  enrolled  486  intervention  participants  from  3  com-
munity health centers in the Denver Health and Hospital 
Authority (DHHA) from March 2007 through June 2009. 
We collected data on 480 comparison patients from 3 other 
DHHA community health centers during the same time. 
This study was reviewed and approved by the Colorado 
Multiple Institutional Review Board. All intervention par-
ticipants verbally consented to participate.
Study setting
DHHA  is  an  urban  safety-net  health  care  system  that 
provides services to 25% of Denver residents, including 
50%  of  Denver’s children  and a  large  proportion of  the 
city’s  indigent,  vulnerable,  and  racial/ethnic  minority 
populations. Clinical care components of DHHA include 
a 500-bed hospital, the 9-1-1 medical response system for 
the city and county of Denver, 8 federally qualified com-
munity health centers, 13 school-based clinics, and Denver 
Public Health.
Patient navigators
The patient navigation model has been successful in facili-
tating care and improving clinical outcomes among cancer 
patients (12). We revised several components of the model 
(eg, staff requirements, training) to tailor it to our CVD 
risk-reduction intervention. Four navigators participated 
in the intervention. Navigators are bilingual (English and 
Spanish) peer counselors, certified in core competencies of 
community health through a 12-week course offered at a 
local community college. Intervention staff educated the 
navigators about intervention objectives and purpose, cal-
culation and use of the FRS, and CVD risk-reduction strat-
egies. We trained n.avigators to identify a participant’s 
readiness to change behaviors, based on the transtheoreti-
cal model (19) and to use motivational interviewing tech-
niques to guide the participant’s goal-setting process. We 
provided additional training on human subjects research, 
privacy  practices,  smoking  cessation,  medication  adher-
ence, cultural competency, and aggression management. 
The  intervention  manager  conducted periodic audits  on 
intervention  delivery  to  assess  navigator  adherence  to 
intervention protocol.
Intervention
The intervention consisted of a 1-hour counseling session, 
conducted by a patient navigator at a community health 
center, plus follow-up telephone calls. During the counseling 
session,  navigators  assessed  participants’  readiness  to 
change  behaviors  and  encouraged  them  to  set  goals. 
The  navigator  and  participant  discussed  potential  CVD 
risk-reduction  activities,  focusing  on  nutrition,  physical 
activity,  and  smoking  cessation.  Navigators  encouraged 
participants  to  continue  or  increase  current  activities 
(eg,  walking),  provided  a  free  3-month  pass  to  local 
Denver  County  recreation  centers,  where  participants 
could engage in exercise programs and bilingual nutrition VOLUME 8: NO. 6
NOVEMBER 2011
  www.cdc.gov/pcd/issues/2011/nov/10_0282.htm • Centers for Disease Control and Prevention  3
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position 
of the Centers for Disease Control and Prevention.
classes, and referred smokers to the Colorado QuitLine, a 
free smoking-cessation program. Although all intervention 
activities were independent of any clinical services, the 
navigator  encouraged  follow-up  with  the  primary  care 
provider for ongoing clinical care.
The navigators called participants at 1 to 4 weeks and 6 
to 10 weeks after enrollment to assist with and encourage 
the chosen behavior changes or participation in interven-
tion activities; additional calls were made within 6 months 
of enrollment. On average, each participant received four 
15-minute calls.
Participant eligibility and recruitment
We identified potential intervention participants in a roll-
ing recruitment process through a CVD registry developed 
for this intervention. We created the registry by collecting 
the  demographic  and  clinical  data  needed  to  calculate 
an  FRS  according  to  methods  outlined  by  Wilson  et  al 
(4): age, sex, diabetes diagnosis (based on codes from the 
International  Classification  of  Diseases,  Ninth  Revision, 
Clinical Modification [ICD-9-CM] [www.cdc.gov/nchs/icd9.
htm] [Appendix]), blood pressure, total cholesterol, high-
density lipoprotein (HDL) cholesterol, and smoking status 
(defined  as  smoking  regularly  during  the  previous  12 
months). The FRS estimates 10-year risk for CHD out-
comes in people who do not have heart disease (4). We 
created 3 strata of risk: low risk, <10%; moderate risk, 
10%  to  20%,  and  high  risk,  >20%.  We  calculated  body 
mass index (BMI) by using weight and height measure-
ments  in  electronic  medical  charts.  We  obtained  family 
history of heart disease by self-report. We collected the 
data from electronic medical record system at the 3 inter-
vention sites. Staff updated the registry monthly, allowing 
identification of potential participants during the 2-year 
recruitment period. In addition, we extracted the following 
demographic information from electronic medical records: 
income and poverty level, race/ethnicity, marital status, 
level of education, and language spoken.
Eligibility requirements for participation in the interven-
tion included having an FRS 10% or greater, being aged 
30 to 64 years, and having an active status at 1 of the 3 
intervention community health centers. We defined active 
as having been seen at least twice during the previous 18 
months; the most recent visit had to be within the previous 
6 months. We excluded patients if they were pregnant or 
lactating; had a history of coronary artery disease, isch-
emic  cardiomyopathy,  myocardial  infarction,  peripheral 
vascular disease, symptomatic carotid artery disease, or 
abdominal  aortic  aneurysm  (based  on  ICD-9-CM  codes 
[Appendix]); or had a comorbid illness with a life expec-
tancy of less than 12 months.
Intervention staff identified 1,425 potentially eligible par-
ticipants from the registry during the 2-year study period; 
506  people  had  inaccurate  contact  information,  leaving 
919 eligible for inclusion. On a monthly basis, staff sent an 
introductory letter explaining the intervention to approxi-
mately 38 patients. Patient navigators followed up by tele-
phone within 2 weeks to assess interest in participation 
and invite participants to the 1-hour counseling session. 
A total of 486 patients verbally consented to participate 
before counseling began.
Not  all  intervention  participants  were  included  in  the 
final analysis. Three participants who experienced a CHD 
event  after  enrollment  were  not  eligible.  We  defined  a 
CHD event as a diagnosis of angina pectoris, myocardial 
infarction, coronary insufficiency (ie, unstable angina), or 
CHD  death  (based  on  ICD-9-CM  codes  [Appendix]);  we 
verified outcomes through chart review. Because the cut-
off date for analysis was June 30, 2008, we excluded 143 
participants who enrolled after this date; 340 participants 
were thus included in the final analysis.
Comparison group eligibility
We used the same eligibility criteria to select a comparison 
group  of  340  patients  from  3  nonintervention  commu-
nity health centers. We matched people in the comparison 
group to intervention participants by age, race/ethnicity, 
sex, and the month and year in which we identified the 
participant for inclusion in the registry; we used this group 
to evaluate the extent to which the changes in the clinical 
outcomes among intervention participants may have been 
related to the intervention. We did not contact or counsel 
people  in  the  comparison  group  or  assess  their  health 
behaviors.
Clinical outcomes
We assessed clinical characteristics at baseline and 12-
month  follow-up  for  both  intervention  and  comparison 
groups. We defined baseline as the date of enrollment for 
the intervention participants and date of record selection 
for the comparison group. In addition to the data collected 
to calculate the FRS at baseline and 12-month follow-up, 
we  extracted  the  following  clinical  data  from  electronic VOLUME 8: NO. 6
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medical  records  for  both  groups:  weight,  height,  low-
density lipoprotein (LDL) cholesterol, and CHD event.
In addition, we collected information on use of medica-
tion for lowering blood pressure or cholesterol levels from 
DHHA pharmacy databases; we defined baseline pick-up 
as pick-up at least twice before study enrollment and fol-
low-up pick-up as pick-up at least twice after study enroll-
ment. We calculated medication adherence as a rate: the 
number  of  days  of  medication  possession  (supply  days 
minus gap days) divided by the number of days of medica-
tion exposure (supply days plus gap days).
For certain clinical characteristics, we established dichoto-
mous categories of “at goal” and “not at goal”: FRS (at goal, 
<10%);  blood  pressure  (at  goal,  <130/80  mm  Hg);  total 
cholesterol (at goal, <160 mg/dL); HDL cholesterol (at goal, 
≥60 mg/dL); and LDL cholesterol (at goal, <100 mg/dL).
Behavioral outcomes
We developed a questionnaire to guide motivational inter-
viewing and assess behavioral outcomes after reviewing 
standardized instruments with demonstrated psychomet-
ric  properties.  The  final  versions  included  30  questions 
designed  to  assess  13  measures  of  nutrition,  physical 
activity  (20),  stages  of  change  for  physical  activity  (21) 
and weight loss (22), depression symptoms (23), tobacco 
use and cessation attempts, and use of nutrition classes 
and recreation centers. We conducted a pilot test on the 
questionnaire to determine the time needed to complete 
it and to assess the target population’s comprehension of 
the questions.
Navigators  administered  the  questionnaire  verbally,  in 
English or Spanish, at baseline in person and at 6-month 
and  12-month  follow-up  by  telephone;  completion  time 
averaged 30 minutes. For follow-up, navigators attempted 
at least 3 telephone calls before considering the partici-
pant lost to follow-up. At 12-month follow-up, navigators 
still attempted to contact participants considered lost to 
follow-up at 6 months. Among 340 participants eligible for 
12-month follow-up, 222 (65%) completed at least 1 follow-
up questionnaire at either 6 months or 12 months.
Statistical analyses
We  generated  descriptive  statistics  on  baseline  demo-
graphic  and  clinical  characteristics  for  the  intervention 
and comparison groups. We performed bivariate analyses 
and measured significant differences between the groups 
by using the χ2 test for proportional comparisons and the 
t test for continuous variables. For clinical outcomes, we 
compared changes from baseline to 12 months between the 
2 groups. To decrease the possibility of selection bias, we 
used an intent-to-treat approach for all analyses.
For behavioral outcomes, we assessed changes from base-
line to follow-up among the intervention participants only. 
If the 12-month questionnaire was missing, we used either 
the baseline questionnaire or the 6-month questionnaire, 
whichever provided the value closest to the 12-month value. 
A series of questions determined the number of fruits and 
vegetables consumed per day and amount of physical activ-
ity per week; the goal for each corresponds to current rec-
ommendations. A series of questions and predefined algo-
rithms defined the stage of change, which we dichotomized 
as  precontemplation/preparation  or  action/maintenance. 
We trichotomized the frequency of consuming high-fat or 
high-calorie foods. We dichotomized other questions as yes 
or no. We assessed significant differences between baseline 
and follow-up in behavioral characteristics by using χ2 anal-
yses. We used SAS version 9.1.3 software (SAS Institute, 
Inc, Cary, North Carolina) to conduct all analyses.
Results
The  participation  rate  for  the  intervention  was  53% 
(486/919). Mean age was 56 years (SD, 6 y). Most (66%) 
participants  were  Hispanic/Latino;  34%  spoke  Spanish 
only. Most (76%) had incomes of 150% or less than the 
federal poverty level. At baseline, almost half of partici-
pants smoked, almost half self-reported a family history of 
heart disease, more than half had hypertension or diabe-
tes, most were overweight or obese (mean BMI, 33kg/m2), 
and the mean FRS was 15.5%. The comparison group was 
similar to the intervention group, except for income; only 
34% of the comparison group had an income of 150% or 
less of the poverty level (χ2 = 209.5, P = .001).
Of the 919 invited to participate, 432 refused participa-
tion.  Major  reasons  for  refusal  included  no  time  (21%), 
no interest (33%), and failure to keep their appointment 
with the navigator (33%). Refusers, compared with par-
ticipants, were significantly more likely to be white non-
Hispanic (34% vs 24%), English speakers (79% vs 66%), 
single (45% vs 35%), and to have a higher baseline total 
cholesterol level (202 mg/dL vs 192 mg/dL). We found no 
other demographic or clinical differences.VOLUME 8: NO. 6
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Clinical outcomes
At follow-up, the mean FRS was significantly lower for the 
intervention group than the comparison group; 11.8% of 
the intervention group was at goal for an FRS, compared 
with 3.5% of the comparison group (Table 1). At follow-up, 
the intervention group had lower mean total cholesterol 
than the comparison group; 29% of the intervention group 
had total cholesterol less than 160 mg/dL compared with 
20%  in  the  comparison  group.  We  found  no  differences 
in blood pressure, weight, or HDL cholesterol. At follow-
up, mean LDL cholesterol was significantly higher in the 
intervention group than in the comparison group, but we 
found no differences between groups in the percentage of 
those with LDL cholesterol less than 100 mg/dL.
The mean baseline rate of cholesterol medication adher-
ence was 70.1% for the intervention group; it increased by 
12.0% to 78.5% at follow-up. The baseline rate for the com-
parison group was 73.9%; it increased by 2.7% to 75.9% at 
follow-up. The increases in medication adherence between 
the 2 groups were significantly different. The mean base-
line  rate  (69.1%)  of  hypertension  medication  adherence 
increased by 9.7% for the intervention group; the mean 
baseline rate (78.8%) for the comparison group increased 
significantly by 4.2%.
There were 3 CHD events in the intervention group and 
4 CHD events in the comparison group between baseline 
and follow-up.
Behavioral outcomes
We found no differences in baseline demographic, behav-
ioral, or clinical characteristics among participants who 
completed a behavioral questionnaire and those who did 
not.
We found significant changes in 10 of 13 behavioral mea-
sures from baseline to 12 months (Table 2). Participants 
reported  significant  improvements  in  all  6  nutritional 
measures.  While  participants  did  not  report  improve-
ment in attaining recommended physical activity levels, 
a significant proportion reported a change from precon-
templation/preparation to action/maintenance for weight 
and exercise. Significantly more participants also reported 
attending an exercise class at follow-up than at baseline. 
Behaviors related to tobacco use and cessation attempts 
did not improve.
Discussion
This intervention, which used patient navigators to encour-
age  CVD  risk-reduction  behaviors  and  connect  patients 
with  community-based  lifestyle-change  services,  demon-
strated improvements in some clinical and behavioral out-
comes for people at risk for CVD. These findings provide 
evidence for using behavioral approaches to reduce CVD 
risk in addition to medical therapy.
The  most  effective  approach  for  CVD  prevention  is  a 
combination of efforts that works at all levels of influence 
to create a social and physical environment that is sup-
portive of healthy behaviors. Evidence supports the use of 
community-based approaches for reducing heart disease 
risk (24-26). Individually adapted health behavior-change 
programs improve participation in physical activity, par-
ticularly  with  improved  access  to  locations  for  physical 
activity (26). Our intervention linked counseling messages 
to the participant’s stage of readiness to focus on behav-
iors the patient was most receptive to modify, an effective 
approach among primary care patients at risk for heart 
disease (27). Using this strategy, we demonstrated several 
behavioral changes and improved medication adherence.
Whereas other successful programs (eg, the Vale study), 
consisting of a more intensive intervention, achieved bet-
ter reductions in cholesterol levels and other coronary risk 
factors (28), our intervention, consisting of an average of 
5 counseling sessions, resulted in improvement in some 
clinical and behavioral outcomes. Patient navigation has 
been used in improving cancer screening and treatment 
outcomes and increasing the use of health care services 
among disenfranchised populations (8,9,11,12). Our inter-
vention, which followed the methodology used in cancer-
prevention patient-navigation programs (12), was able to 
enhance the traditional clinical approaches for reducing 
CVD risk, suggesting that this model could be used for 
various chronic disease prevention activities (18).
Our study had limitations. For the clinical analyses, lack 
of  randomization  increased  the  possibility  of  selection 
bias and confounding. Matching at-risk comparison group 
members  with  intervention  participants  attenuates  this 
possibility;  the  demographic  and  clinical  characteristics 
of  the  2  groups  were  similar,  except  for  income  levels. 
The participation rate of 53% may reflect the population 
often  served  by  safety-net  institutions;  this  population, 
composed largely of low-income and racial/ethnic minor-
ity  patients,  may  harbor  distrust  in  clinical  programs. VOLUME 8: NO. 6
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Nevertheless,  we  observed  minimal  differences  between 
intervention participants and people who refused to par-
ticipate. Another possible limitation is that only 65% of 
the eligible participants completed a follow-up behavioral 
assessment.  We  used  intent-to-treat  analyses  to  avoid 
selection bias. We found no differences in baseline charac-
teristics between participants who completed a follow-up 
assessment and those who did not. Because we did not 
assess  behavior  changes  in  the  comparison  group,  we 
cannot rule out that behavior changes identified in the 
intervention group were caused by factors other than the 
patient navigators. Future studies will need to examine 
health behaviors of both groups to fully assess the effect of 
using patient navigators. Finally, because follow-up was 
only for 1 year, the study was not able to assess the long-
term effect of the intervention on CHD events.
Using patient navigators to provide individualized counsel-
ing, assistance in goal setting, and linkage to community 
resources, seems to help intervention participants achieve 
positive  behavior  change  (particularly  related  to  nutri-
tional  activities)  and  improve  several  clinical  outcomes. 
This intervention potentially offers a simple intervention 
for  enhancing  traditional  clinical  CVD  risk-reduction 
services. Future studies should consider conducting more 
rigorous evaluations of the effect of patient navigators on 
changes in health behaviors.
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Tables
Table 1. Clinical Characteristics Among Intervention and Comparison Groups Eligible for 12-Month Follow-Up (Intent-to-Treat 
Analysis), Study on Use of Patient Navigators to Reduce Risk for Cardiovascular Disease, Denver, Colorado, 2007-2009
Characteristic
Baselinea 12-Month Follow-Upb
Intervention 
Group 
(n= 486)
Comparison 
Group 
(n= 480) P Value
Intervention 
Group 
(n = 340)
Comparison 
Group 
(n = 340) P Value
Framingham risk score, %c
Mean (SD) 1. (6.2) 1.0 (.9) .22d 14.8 (6.) 1.8 (6.0) .03d
<10, no. (%) 0 0 NC 40 (11.8) 12 (3.) <.001e
10-20, no. (%) 408 (84) 420 (8) .11e 2 (.0) 2 (81.) .04e
>20, no. (%) 8 (16) 60 (13) .11e 4 (13.2) 1(1.0) .0e
Blood pressure, mm Hg
Mean (SD) 138/81 (18/11) 140/84 (20/10) .13/<.001d 139/81(18/12) 139/83 (19/9) .9/.02d
<130/80, No. (%) 119 (24.) 93 (19.4) .06e 80 (23.) 66 (19.4)
.19e
≥130/80, No. (%) 36 (.) 38 (80.6) 260 (6.) 24 (80.6)
Weight, lb
Mean (SD) 194 (43) 191 (46) .22d 19 (44) 191 () .28d
Total cholesterol, mg/dL
Mean (SD) 192 (40) 19 (48) .0d 183 (44) 19 (49) <.001d
<160, No. (%) 6 (16) 86 (18) .34e 99 (29) 68 (20)
<.001e
≥160, No. (%) 410 (84) 394 (82) 241 (1) 22 (80)
High-density lipoprotein cholesterol, mg/dL
Mean (SD) 44 (10) 44 (12) .96d 44 (10) 44 (12) .4d
<60, No. (%) 4 (94) 443 (92) .28e 316 (93) 312 (92)
.6e
≥60, No. (%) 29 (6) 3 (8) 24 () 28 (8)
Low-density lipoprotein cholesterol, mg/dL
Mean (SD) 114 (3) 112 (39) .39d 118 (3) 111 (40) .02d
<100, No. (%) 181 (38) 18 (40) .63e 120 (36) 133 (40)
.21e
≥100, No. (%) 294 (62) 282 (60) 218 (64) 198 (60)
 
Abbreviation: NC, not calculated; SD, standard deviation. 
a Intervention group includes all people enrolled in the intervention; intervention participants received services from a patient navigator, including counseling 
and referral to community-based lifestyle behavior-change services. Baseline comparison group includes people who met eligibility requirements for enrollment 
but did not receive the intervention. 
b Includes intervention participants and comparison group members eligible for 12-month follow-up. Not eligible for follow-up were 3 intervention participants 
and 4 comparison group members who had a coronary heart disease event. If no clinical follow-up was completed, we assumed no change occurred and used 
baseline values. 
c The Framingham risk score estimates 10-year risk for coronary heart disease outcomes in people who do not have heart disease (4). 
d P value calculated by using pooled t test with equal variances; it compares intervention and comparison groups. 
e P value calculated by using χ2 test; it compares intervention and comparison groups.VOLUME 8: NO. 6
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Table 2. Change in Behavioral Characteristics Among Intervention Participants Eligible for 12-Month Follow-Up (Intent-to-Treat 
Analysis), Study on Use of Patient Navigators to Reduce Risk for Cardiovascular Disease, Denver, Colorado, 2007-2009
Characteristic
Baseline,a 
No. (%) 
(n = 343)
12-Month Follow-Up,b 
No. (%) 
(n = 340) P Valuec
Consume ≥5 servings of fruits and/or vegetables per day
Yes  (2.0) 32 (9.8) <.001
No 336 (98.0) 294 (90.3)
During the past 7 days, number of times drank soda
None 16 (48.8) 206 (63.4) <.001
≤Once per day 13 (39.) 96 (29.)
≥Twice per day 40 (11.) 23 (.1)
During the past 7 days, number of times pastry eaten
None 84 (24.) 14 (4.1) <.001
≤Once per day 23 (69.1) 166 (0.9)
≥Twice per day 22 (6.4) 13 (4.0)
During the past 7 days, number of times fried foods eaten
None 83 (24.3) 133 (40.1) <.001
≤Once per day 232 (6.8) 183 (6.1)
≥Twice per day 2 (.9) 10 (3.1)
During the past 7 days, how often did you read labels?
Never or rarely 212 (61.8) 12 (46.8) <.001
Sometimes or more often 131 (38.2) 13 (3.2)
Attended a nutrition class in the last 6 months
Yes 13 (3.8) 49 (1.0) <.001
No 330 (96.2) 2 (8.0)
Stage of change regarding weight
Precontemplation/preparation 120 (3.) 8 (24.) .002
Action/maintenance 218 (64.) 240 (.)
Physical activity leveld
At or above recommended level 13 (40.) 129 (38.2) .64
Below recommended level 198 (9.) 209 (61.8)
 
a At baseline, intervention group includes all people enrolled in the intervention; intervention participants received services from a patient navigator, including 
counseling and referral to community-based lifestyle behavior-change services. Baseline comparison group includes people who met eligibility requirements for 
enrollment but did not receive the intervention. 
b Includes all intervention participants eligible for the 12-month follow-up interview but excludes 3 who had a coronary heart disease event. If the 12-month 
questionnaire was missing, we used either the baseline questionnaire or the 6-month questionnaire, whichever provided the value closest to the 12-month 
value. 
c P value calculated by using χ2 test; it compares baseline with 12-month follow-up. 
d Recommended physical activity level defined as 30 minutes of moderate activity or walking  or more days per week.
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Characteristic
Baseline,a 
No. (%) 
(n = 343)
12-Month Follow-Up,b 
No. (%) 
(n = 340) P Valuec
Stage of change regarding exercise
Precontemplation/preparation 82 (32.0) 4 (19.0) .001
Action/maintenance 14 (68.0) 201 (81.0)
Attended an exercise class in the last 6 months
Yes 3 (10.2) 94 (29.1) <.001
No 30 (89.8) 229 (0.9)
Current smoker
Yes 11 (34.2) 9 (30.8) .32
No 22 (6.8) 218 (69.2)
Among smokers, tried to quit in last 12 months
Yes 62 (4.9) 4 (49.) .46
No 1 (4.1) 48 (0.)
Over the last 2 weeks, felt depressed for several days or more
Yes 188 (.0) 109 (33.) <.001
No 14 (4.0) 216 (66.)
 
a At baseline, intervention group includes all people enrolled in the intervention; intervention participants received services from a patient navigator, including 
counseling and referral to community-based lifestyle behavior-change services. Baseline comparison group includes people who met eligibility requirements for 
enrollment but did not receive the intervention. 
b Includes all intervention participants eligible for the 12-month follow-up interview but excludes 3 who had a coronary heart disease event. If the 12-month 
questionnaire was missing, we used either the baseline questionnaire or the 6-month questionnaire, whichever provided the value closest to the 12-month 
value. 
c P value calculated by using χ2 test; it compares baseline with 12-month follow-up. 
d Recommended physical activity level defined as 30 minutes of moderate activity or walking  or more days per week.
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Appendix. Diagnosis Codes Used to Assess Eligibility for Study on Patient Navigators, 
Denver, Colorado, 2007-2009
Codes were obtained from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) (www.cdc.gov/nchs/icd9.htm).
Diagnosis Code
Cardiomyopathy 414.8
Coronary artery disease 411.0, 411.1, 411.8, 411.81, 411.89, 414.0, 414.00, 414.01, 414.02, 414.03, 414.04, 414.0, 
414.06, 414.0, 414.10, 414.11, 414.12, 414.8, 414.9
Myocardial infarction 410.0, 410.00, 410.01, 410.02, 410.1, 410.10, 410.11, 410.12, 410.2, 410.20, 410.21, 410.22, 
410.3, 410.30, 410.31, 410.32, 410.4, 410.40, 410.41, 410.42, 410., 410.0, 410.1, 410.2, 
410.6, 410.60, 410.61, 410.62, 410., 410.0, 410.1, 410.2, 410.8, 410.80, 410.81, 410.82, 
410.9, 410.90, 410.91, 410.92
Peripheral vascular disease 440.0, 440.1, 440.2, 440.20, 440.21, 440.22, 440.23, 440.24, 440.29, 440.30, 440.31, 440.32, 
440.8, 440.9, 443.21, 443.89, 443.9
Symptomatic carotid artery disease 433.1, 433.11, 43.3, 442.81, 900.00, 900.01, 900.02, 900.03, 996.1
Abdominal aortic aneurysm 093.0, 441.3, 441., 441.9
Diabetes 20, 20.00, 20.01, 20.02, 20.03, 20.10, 20.11, 20.12, 20.13, 20.20, 20.21, 20.22, 
20.23, 20.30, 20.31, 20.32, 20.33, 20.40, 20.41, 20.42, 20.43, 20.0, 20.1, 
20.2, 20.3, 20.60, 20.61, 20.62, 20.63, 20.0, 20.1, 20.2, 20.3, 20.80, 
20.81, 20.82, 20.83, 20.90, 20.91, 20.92, 20.93, 648.00, 648.01, 648.02, 648.03, 
648.04
 